Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Applied Therapeutics Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Contineum Therapeutics, Inc. Class A (CTNM – Resea...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Contineum Therapeutics, Inc. Class A (CTNM), Xoma (XOMA) and Applied Therapeutics (APLT)

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on Applied Therapeutics, with a price target of $0.25. The...

Current Quarter	$-0.09	Next Quarter	$-0.1
Current Year	$-0.52	Next Year	$-0.47
QoQ Growth	-11.1%	YoY Growth	+9.6%
3Y EPS CAGR	+43.1%	Target Price	$0.25
Consensus	Buy	Upside	+116.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	APLT	$0.12	-0.26%	35.00M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	APLT	$0.12	-0.3%	35.00M
3
4
5
6

APLT

APLT

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Applied Therapeutics Inc. Data in Excel

Get Applied Therapeutics Inc. Data in Excel